The OSMR Gene Amyloidosis Primary Localized Cutaneous Type 1 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at detecting mutations in the OSMR gene that are associated with Primary Localized Cutaneous Amyloidosis Type 1 (PLCA1). This condition is a rare skin disorder characterized by the deposition of amyloid proteins in the skin, leading to itchy, scaly, or lichenoid eruptions primarily affecting the shins, thighs, feet, and forearms.
The test is pivotal for individuals exhibiting symptoms of PLCA1 or those with a family history of the condition, as it aids in confirming the diagnosis, understanding the risk of transmission to offspring, and guiding management and treatment decisions. By analyzing the genetic makeup of an individual, specifically targeting the OSMR gene, healthcare providers can identify mutations that are known to contribute to the development of this form of amyloidosis.
At DNA Labs UAE, the test is priced at 4400 AED. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then examined in the laboratory using advanced genetic sequencing technologies. Results from the test can provide crucial insights into the genetic underpinnings of the disease, allowing for a more targeted approach to treatment and counseling for affected individuals and their families.
The IL31RA Gene Amyloidosis Primary Localized Cutaneous Type 2 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE. Priced at 4400 AED, this test specifically targets the IL31RA gene to detect mutations associated with Primary Localized Cutaneous Amyloidosis Type 2 (PLCA2), a rare skin disorder. This condition is characterized by the deposition of amyloid proteins in the skin, leading to various dermatological manifestations such as itching, lichen, or macular papules. The genetic test is crucial for confirming the diagnosis, understanding the risk of inheritance, and guiding treatment strategies. By analyzing the patient's DNA sample, the test can identify specific genetic alterations in the IL31RA gene, providing valuable insights into the condition's etiology and potential management options. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step towards personalized medicine in dermatology, offering patients and their families critical information for managing PLCA2.
The TPM2 Gene Arthrogryposis Distal Type 1A Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the TPM2 gene that are associated with Arthrogryposis Distal Type 1A, a rare genetic disorder. This condition primarily affects the development and flexibility of the joints, leading to congenital contractures in the distal limbs (hands and feet), which can significantly impact mobility and quality of life. The test, priced at 4400 AED, involves analyzing the patient's DNA to identify any genetic anomalies in the TPM2 gene, which plays a crucial role in muscle contraction and development. Early detection through this genetic testing can facilitate timely intervention and management strategies, potentially improving outcomes for affected individuals. DNA Labs UAE provides this test with the aim of offering accurate, reliable genetic insights for families and individuals facing the challenges of Arthrogryposis Distal Type 1A.
The MYBPC1 gene plays a crucial role in the development and function of skeletal muscles. Mutations in the MYBPC1 gene are associated with Arthrogryposis Distal Type 1B, a rare genetic disorder characterized by congenital joint contractures that develop before birth. These contractures affect two or more areas of the body, leading to limited movement and flexibility in the affected joints. Arthrogryposis Distal Type 1B specifically refers to the form of the condition where the distal limbs are involved.
To diagnose this condition, a genetic test targeting the MYBPC1 gene can be conducted. This test is crucial for confirming the diagnosis, understanding the disease's progression, and informing treatment and management strategies. DNA Labs UAE offers this specialized genetic test for Arthrogryposis Distal Type 1B, providing a vital resource for affected individuals and their families.
The cost of the MYBPC1 Gene Arthrogryposis Distal Type 1B Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the genetic analysis required to detect mutations in the MYBPC1 gene that are indicative of Arthrogryposis Distal Type 1B. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of the condition, enabling informed decisions about care and management.
The MYH3 gene plays a crucial role in the development and function of muscles and skeletal structures in the human body. Mutations in the MYH3 gene are associated with Arthrogryposis Multiplex Congenita, specifically Distal Type 2A, a condition characterized by congenital joint contractures in two or more areas of the body, affecting the movement and position of the limbs. The condition can lead to significant physical disability.
The genetic test for MYH3 gene mutations related to Arthrogryposis Distal Type 2A is a critical tool for diagnosing this condition. This test examines the MYH3 gene for specific mutations known to cause the disorder, providing essential information for accurate diagnosis, management, and genetic counseling.
In the United Arab Emirates, this specialized genetic test is available at DNA Labs UAE, a leading facility known for its advanced diagnostic services. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the MYH3 gene. This test is a valuable resource for families and individuals seeking answers about this rare and challenging condition, offering hope for better management and understanding of Arthrogryposis Distal Type 2A.
The MYH3 Gene Arthrogryposis Distal Type 2B Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the MYH3 gene, which are linked to the development of Arthrogryposis Distal Type 2B. This condition is a rare genetic disorder characterized by severe joint contractures and muscle weakness present at birth, primarily affecting the hands and feet. The test plays a crucial role in the early diagnosis and management of the disorder, enabling healthcare professionals to tailor treatment plans and provide genetic counseling to affected families. Priced at 4400 AED, this test is a valuable resource for individuals with a family history of the condition or presenting symptoms suggestive of Arthrogryposis Distal Type 2B, offering insights into the genetic basis of their condition and guiding clinical decisions.
The TNNI2 gene arthrogryposis distal type 2B genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the TNNI2 gene, which are associated with arthrogryposis distal type 2B (ADT2B). ADT2B is a rare genetic disorder characterized by congenital joint contractures that primarily affect the hands and feet, leading to limited movement and possible deformity of the affected areas. The TNNI2 gene encodes a protein essential for muscle contraction, and mutations in this gene can disrupt normal muscle development and function, resulting in the symptoms observed in ADT2B.
This genetic test is crucial for accurate diagnosis, enabling targeted interventions and management strategies to improve the quality of life for affected individuals. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the TNNI2 gene.
The cost of the TNNI2 gene arthrogryposis distal type 2B genetic test at DNA Labs UAE is 4400 AED. This price may cover the testing procedure, analysis, and detailed report of the findings, but it's advisable to confirm with the laboratory for a comprehensive breakdown of the cost. Early and accurate diagnosis through this genetic test can significantly impact the management and treatment options for individuals with ADT2B, offering them a better prognosis and improved quality of life.
The TNNT3 Gene Arthrogryposis Distal Type 2B Genetic Test is a specialized diagnostic assessment performed to identify mutations in the TNNT3 gene, which are associated with Arthrogryposis Distal Type 2B (ADT2B). This condition is a form of arthrogryposis, characterized by congenital joint contractures in two or more areas of the body, affecting the distal limbs. The TNNT3 gene plays a crucial role in muscle contraction, and mutations in this gene can lead to muscle weakness and developmental issues in the affected limbs.
This genetic test is crucial for early diagnosis and management of ADT2B, allowing for tailored treatment plans that can include physical therapy, surgical interventions, and supportive care to improve mobility and quality of life for affected individuals. Early diagnosis through genetic testing can also provide valuable information for family planning and understanding the risk of recurrence in future pregnancies.
The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high-quality testing standards and accurate results. The cost of the TNNT3 Gene Arthrogryposis Distal Type 2B Genetic Test is 4400 AED, reflecting the specialized nature of the test and the sophisticated technology used in identifying the genetic mutations associated with this condition.
The PIEZO2 Gene Arthrogryposis Distal Type 3 Genetic Test is a specialized diagnostic tool designed to detect mutations in the PIEZO2 gene, which are associated with Arthrogryposis Distal Type 3, a rare genetic disorder. This condition is characterized by congenital contractures in the distal parts of the limbs, affecting the movement and positioning of the hands and feet. The test involves analyzing the patient's DNA to identify any genetic alterations in the PIEZO2 gene that could lead to the disorder.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, this test provides crucial information for families and healthcare providers. It aids in the early diagnosis, management, and understanding of the condition, allowing for better-informed decisions regarding care and treatment options. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to accurately interpret the results. Through this testing, individuals and families gain valuable insights into the genetic underpinnings of Arthrogryposis Distal Type 3, empowering them with knowledge to tackle the challenges associated with the condition.
The PIEZO2 Gene Arthrogryposis Distal Type 5 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PIEZO2 gene, which are associated with Arthrogryposis Distal Type 5. This condition is a rare genetic disorder characterized by congenital contractures that lead to limited movement in the affected joints, primarily in the hands and feet. The PIEZO2 gene plays a crucial role in the body's mechanosensory functions, which include touch sensation and proprioception - the awareness of body position and movement. Mutations in this gene can disrupt these processes, leading to the symptoms observed in patients with Arthrogryposis Distal Type 5.
The genetic test involves analyzing the patient's DNA to detect mutations in the PIEZO2 gene that are linked to the disorder. This test is pivotal for accurate diagnosis, enabling healthcare professionals to provide appropriate management and treatment plans tailored to the individual's condition. The cost of the PIEZO2 Gene Arthrogryposis Distal Type 5 Genetic Test at DNA Labs UAE is 4400 AED. This investment allows patients and their families to gain valuable insights into the genetic underpinnings of the condition, facilitating informed decisions regarding care and support.
